Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
Mr. Michael Feldschuh est le Chairman of the Board de Daxor Corp, il a rejoint l'entreprise depuis 2013.
Quelle est la performance du prix de l'action DXR ?
Le prix actuel de DXR est de $10.18, il a diminué de 6.94% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Daxor Corp ?
Daxor Corp appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Daxor Corp ?
La capitalisation boursière actuelle de Daxor Corp est de $59.3M
Est-ce que Daxor Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 4 analystes ont établi des notations d'analystes pour Daxor Corp, y compris 1 achat fort, 3 achat, 1 maintien, 0 vente et 1 vente forte